(NASDAQ: COCP) Cocrystal Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.06%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.08%.
Cocrystal Pharma's earnings in 2025 is -$15,849,000.On average, 3 Wall Street analysts forecast COCP's earnings for 2025 to be -$10,817,791, with the lowest COCP earnings forecast at -$15,057,209, and the highest COCP earnings forecast at -$8,647,722. On average, 2 Wall Street analysts forecast COCP's earnings for 2026 to be -$11,801,596, with the lowest COCP earnings forecast at -$14,446,782, and the highest COCP earnings forecast at -$9,156,411.
In 2027, COCP is forecast to generate -$12,208,548 in earnings, with the lowest earnings forecast at -$12,208,548 and the highest earnings forecast at -$12,208,548.